Nevada
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Nevada: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Nevada law aligns largely with the federal standard concerning patent eligibility and the exclusion of natural phenomenon from patentability. However, Nevada courts may emphasize state statutes and local precedents when adjudicating on intellectual property issues.
In accordance with Nevada Revised Statutes (NRS) 600.050, an invention that is a law of nature or a natural phenomenon is not patentable.
The Nevada Supreme Court upheld the principles established in association for Molecular Pathology, ruling that similar biological patents were not eligible for patent protection under state law.
The court found that patents for naturally derived substances could not be enforced when the substance was already known in nature, affirming the natural exclusion.
The court ruled that the claims concerning genetic sequences did not meet the thresholds for patentability under both state and federal standards.
Nevada's approach mirrors federal principles established under 35 U.S.C. § 101, which limits patent eligibility to inventions that are not merely natural phenomena. However, Nevada courts may also incorporate a more rigorous review of local patent applications compared to a broader federal standard, potentially leading to different outcomes in similar cases.
Understanding the principles from Association for Molecular Pathology is crucial, as questions about patent eligibility and the exceptions to patentability frequently appear in the Nevada bar exam.